Table 2. Endoscopic retrograde cholangiopancreatography (ERCP)-related procedures (n = 59) and their adverse events.
ERCP-related procedure, n (%) | |
|
34 (58 %) |
|
47 (80 %) |
|
47 (80 %) |
ERCP-related adverse events, n (%) | |
|
2 (3 %) |
|
0 |
|
0 |
|
0 |
ERCP, endoscopic retrograde cholangiopancreatography.